MicroRNA are emerging as important regulators of gene expression and their deregulation has been extensively reported in human malignancies. A restricted number of microRNAs was found upregulated in several different human cancers. Among these “oncomiRs”, miR-221 was reported to be up-regulared in glioblastoma, urinary bladder cancer, papillary tumours of the thyroid, pancreatic cancer, hepatocellular carcinoma and prostate carcinoma. Advances in the knowledge of microRNA potentiality in cancer treatment have led to the development of Antagomirs and LNA-modified anti-miRNAs, chemically-stabilized oligonucleotides able to inhibit microRNA functions. Beside p27 and p57, here we report Bmf as a target of miR-221, outlining the role of this microRNA in the control of both proliferation and apoptosis and contributing to characterize its role in liver cancerogenesis. Moreover, miR-221 over-expression was found to be associated with a more aggressive HCC phenotype, confirming miR-221 as a possible target for non-conventional molecular-targeted treatment against HCC.

MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality

FERRACIN, Manuela;VERONESE, Angelo;SABBIONI, Silvia;Grazi G. L.;CROCE, Carlo Maria;NEGRINI, Massimo
2009

Abstract

MicroRNA are emerging as important regulators of gene expression and their deregulation has been extensively reported in human malignancies. A restricted number of microRNAs was found upregulated in several different human cancers. Among these “oncomiRs”, miR-221 was reported to be up-regulared in glioblastoma, urinary bladder cancer, papillary tumours of the thyroid, pancreatic cancer, hepatocellular carcinoma and prostate carcinoma. Advances in the knowledge of microRNA potentiality in cancer treatment have led to the development of Antagomirs and LNA-modified anti-miRNAs, chemically-stabilized oligonucleotides able to inhibit microRNA functions. Beside p27 and p57, here we report Bmf as a target of miR-221, outlining the role of this microRNA in the control of both proliferation and apoptosis and contributing to characterize its role in liver cancerogenesis. Moreover, miR-221 over-expression was found to be associated with a more aggressive HCC phenotype, confirming miR-221 as a possible target for non-conventional molecular-targeted treatment against HCC.
Gramantieri, L.; Fornari, F.; Ferracin, Manuela; Veronese, Angelo; Sabbioni, Silvia; Calin, G. A.; Grazi, G. L.; Croce, Carlo Maria; Bolondi, L.; Negrini, Massimo
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/534987
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 271
  • ???jsp.display-item.citation.isi??? 253
social impact